Wednesday - December 12, 2012

ASMI elects a new President

The Australian Self-Medication Industry (ASMI) today announced the election of a new President and office bearers, to guide the strategic direction of the organisation.

The ASMI Committee of Management, which controls and manages the affairs of the association, made the following appointments:

·         The newly elected ASMI President is Mark Sargent, General Manager, Australia & New Zealand, Consumer Care, Bayer Australia;

·         The newly elected ASMI Vice President (Secretary) is Ralf Dahmen, Managing Director, Omega Pharma Australia & New Zealand;

·         The re-elected ASMI Vice President (Treasurer) is Trevor Norman, General Manager, Combe Asia-Pacific.

The Executive Director of ASMI, Dr Deon Schoombie congratulated the newly elected team and extended his gratitude to the immediate past president of ASMI, Lindsay Forrest.

“I would like to congratulate Mark Sargent on assuming the role of President of ASMI. He is an extremely experienced senior executive with a deep understanding of the industry. I am delighted that we will have the benefit of one of our most accomplished executives to help guide our future direction at this critical time,” Dr Schoombie said.

Mark has over 15 years’ experience in senior marketing, sales and management roles, including 10 years in the over-the-counter medicines sector in Australia and globally, most recently at Roche Consumer Health and Bayer Consumer Care.

Mark has been an active member of the ASMI Committee of Management, and Chair of the Self Care sub-committee. He has an MBA from the Australian Graduate School of Management and a Bachelor of Commerce (Marketing) from the University of NSW.

“It is a great honour to take over the President’s role and I look forward to the challenges and opportunities that lay ahead,” Mr Sargent said.

“There are a number of key policy and regulatory issues that will be extremely important for the industry over the coming year. These include business reform at the TGA, reviews into medicines labelling and packaging, a new trans-Tasman regulatory model, reform of complementary medicines, fresh approaches to medicines scheduling and promotion, and the advancement of consumer self care.

“I am looking forward to playing my part in advancing a strong, sustainable industry and the best possible health outcomes for consumers,” he said.

Dr Schoombie also congratulated Ralf Dahmen on his election as Vice President (Secretary), and Trevor Norman on his re-election as Vice President (Treasurer).

Ralf Dahmen is a former ASMI President and Honorary Life Member. Trevor Norman has served on the Committee of Management since 2003.

“We are very fortunate to have the services of these two vastly experienced figures in the industry and I look forward to continuing to work with them in these important roles,” Dr Schoombie said.

He also paid tribute to Lindsay Forrest, who is retiring from Reckitt Benckiser at the end of this year and, stepping down from the ASMI presidency.

“I would like to extend my deepest appreciation to Lindsay who has served with distinction, and been both an outstanding ambassador for the industry and a great source of strategic advice and counsel for ASMI. I wish him all the very best in his retirement”.